Advertisement

Topics

Positive long-term results reported for Leber’s hereditary optic neuropathy treatment

08:03 EDT 15 Jun 2017 | Healio

GenSight Biologics has reported that GS010, an intravitreal injection treatment for Leber’s hereditary optic neuropathy, has shown positive long-term visual acuity and safety results after 96 weeks, according to a company press release.In the phase 1/2 trial, a single intravitreal injection of GS010 was administered in the eye most severely affected by the disease.

Original Article: Positive long-term results reported for Leber’s hereditary optic neuropathy treatment

NEXT ARTICLE

More From BioPortfolio on "Positive long-term results reported for Leber’s hereditary optic neuropathy treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...